FASEB SRC: The Post-transcriptional Control of Gene Expression Conference: Mechanisms of RNA Decay
FASEB SRC:基因表达转录后控制会议:RNA 衰变机制
基本信息
- 批准号:10467761
- 负责人:
- 金额:$ 0.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-19 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsBackBacteriaBiological ProcessBiologyBiomedical ResearchCOVID-19COVID-19 pandemicCessation of lifeClinicalClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunicable DiseasesCommunitiesComplexDefectDegradation PathwayDevelopmentEducational workshopEnvironmentEnzymesEukaryotaEvaluationFacultyFloridaFosteringGene ExpressionGene Expression RegulationGenetic DiseasesGenetic TranscriptionGoalsHospitalizationHumanHuman GeneticsJupiterLeadershipLifeLinkMessenger RNAModernizationModificationMolecular BiologyMuscleMutationOrganismPaperParticipantPathway interactionsPatientsPortugalPost-Transcriptional RegulationPostdoctoral FellowProkaryotic CellsProtein BiosynthesisProteinsRNARNA DecayRNA DegradationRNA InterferenceRNA ProcessingRNA VirusesRNA vaccineRegulationResearchResearch PersonnelRespondentSTEM fieldScheduleScientistScourgeSenior ScientistSeriesSiteSpinalSpinal Muscular AtrophyStructureTimeTranscriptional RegulationVirusWomancareercareer developmentclinical applicationcostdisease-causing mutationenzyme pathwayexpectationgraduate studentmRNA Decaymeetingsmenpandemic diseasepathogenic bacteriapathogenic virusplant fungiresponsesenior facultysymposiumtoolvirtual
项目摘要
PROJECT SUMMARY
The understanding that RNA degradation is critical for gene expression traces back to 1959 when Pardee, Jacob
and Monod demonstrated in a historical paper that there had to be an unstable intermediate directing protein
synthesis. More recently, the spectacular use of RNA interference to experimentally degrade specific mRNAs
has expanded the applications of understanding RNA decay mechanisms beyond any expectations. The clinical
applications in the post-transcriptional regulation/RNA field are only starting to be realized with the initial
development of Nusinersen/Spinraza® to successfully treat Spinal Muscular Atrophy and the more recent
description of Milasin® to treat a single patient through a personalized RNA therapy. Of course in late 2019 into
early 2020, RNA burst on to the global stage in a way we could not have predicted with the COVID-19 RNA virus
impacting life as we know it across the globe. Who would or could have guessed that RNA could also represent
a potential path back to a new normal via the rapid development and deployment of the first mRNA vaccines. All
of these examples highlight why The FASEB meeting on ‘Post-transcriptional Regulation of Gene Expression:
Mechanisms of RNA Decay’ is such a timely conference to support at this juncture. This meeting has developed
into a unique conference that brings together the leading experts in RNA decay in humans and other metazoan
animals, plants, fungi, viruses, and bacteria. This meeting is the 12th is a series of FASEB meetings on this topic
where there is a long tradition of sharing key discoveries, building collaborations, and contributing to career
development for junior scientists in the field. This meeting, which, after a two year delay due to the global
pandemic, will be held June 19-23, 2022 in Jupiter, Florida, is being co-organized by three leaders in the RNA
decay field, Dr. Anita H. Corbett from Emory, USA, Dr. Lori Passmore from the MRC in Cambridge UK, and Dr.
Cecilia Arraiano from the ITQB/Universidade NOVA de Lisboa, Portugal. Under this leadership, we propose
three specific aims: 1) Bring together the RNA degradation field and provide a forum for the presentation and
discussion of the latest advances; 2) Provide an inclusive environment for establishing collaborations between
researchers studying RNA degradation with different approaches and in different organisms; and 3) Encourage
productive interactions between a diverse group of both junior scientists and leaders in the RNA degradation
field. In keeping with a meeting goal and a common passion of the organizers, this meeting is organized with a
major commitment to inclusive excellence. Among the 35 invited speakers thus far, there are 18 women (51%)
and 17 men (49%). Each session is chaired by a co-chair team consisting of a senior scientist and a junior
scientist. Among the 18 co-chairs, 11 (61%) are women. We are excited to include five co-chairs who are from
groups traditionally underrepresented in STEM fields (28%). The long-term goal is to continue a successful
meeting series that addresses modern and timely topics in RNA decay and processing while building a diverse
and inclusive community of collaborative scientists and colleagues.
项目摘要
理解RNA降解对于基因表达至关重要,可以追溯到1959年,当时雅各布
Monod在一篇历史论文中证明了必须有一个不稳定的中间引导蛋白
合成。最近,RNA干扰对实验降解特定mRNA的壮观使用
已经扩大了理解RNA衰减机制的应用,超出了任何期望。临床
转录后调节/RNA场中的应用刚刚开始使用初始
Nusinersen/Spinraza®的开发成功治疗脊柱肌肉萎缩和最近
Milasin®的描述通过个性化的RNA疗法来治疗单个患者。当然在2019年底进入
2020年初,RNA以某种方式进入全球阶段,我们无法预测Covid-19 RNA病毒
影响着我们在全球所知的生活。谁会或可能猜到RNA也可以代表
通过快速开发和部署第一种mRNA疫苗的潜在途径回到新的正常状态。全部
在这些示例中,强调了为什么FASEB会议会议上有关基因表达的转录后调节:
RNA Decay’的机制是一个及时的会议,可以在此关头支持。这次会议已经发展
进入一个独特的会议,汇集了人类和其他后生动物RNA衰变领先的专家
动物,植物,真菌,病毒和细菌。这次会议是第十二次会议是有关此主题的一系列Faseb会议
在共享关键发现,建立合作和为职业贡献的悠久传统的地方
该领域初级科学家的发展。这次会议,由于全球延迟两年后
大流行将于2022年6月19日至23日在佛罗里达州的木星举行
美国埃默里(Emory)的Anita H. Corbett博士,英国剑桥的MRC的Lori Passmore博士和博士
葡萄牙ITQB/ITQB/Universidade Nova de Lisboa大学的Cecilia Arraiano。在这个领导下,我们建议
三个具体目的:1)将RNA降解领域汇总在一起,并为演示文稿提供论坛
讨论最新进展; 2)提供一个包容性的环境,以建立合作
研究人员使用不同的方法和不同生物体研究RNA降解; 3)鼓励
RNA降解中的一个初级科学家和领导者的潜水员群体之间的生产互动
场地。为了符合会议目标和组织者的共同热情,这次会议是由
对包容性卓越的主要承诺。到目前为止,在35名受邀演讲者中,有18名妇女(51%)
和17人(49%)。每个会议由一个由高级科学家和初中组成的联合主席团队主持
科学家。在18个联合主席中,有11名(61%)是女性。我们很高兴包括五个来自的联合主席
传统上,茎领域中的人为不足(28%)。长期目标是继续成功
会议系列介绍了RNA衰变和处理中的现代和及时主题,同时建立潜水员
以及合作科学家和同事的包容性社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANITA H. CORBETT其他文献
ANITA H. CORBETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANITA H. CORBETT', 18)}}的其他基金
A Conserved RNA Binding Protein Required for Control of Key Developmental Pathways
控制关键发育途径所需的保守 RNA 结合蛋白
- 批准号:
10551324 - 财政年份:2022
- 资助金额:
$ 0.65万 - 项目类别:
A Conserved RNA Binding Protein Required for Control of Key Developmental Pathways
控制关键发育途径所需的保守 RNA 结合蛋白
- 批准号:
10391721 - 财政年份:2022
- 资助金额:
$ 0.65万 - 项目类别:
The role of novel oncogenic histone H3 lysine variants in defining a therapeutically actionable epigenetic signature
新型致癌组蛋白 H3 赖氨酸变体在定义治疗上可行的表观遗传特征中的作用
- 批准号:
10436987 - 财政年份:2021
- 资助金额:
$ 0.65万 - 项目类别:
The role of novel oncogenic histone H3 lysine variants in defining a therapeutically actionable epigenetic signature
新型致癌组蛋白 H3 赖氨酸变体在定义治疗上可行的表观遗传特征中的作用
- 批准号:
10290714 - 财政年份:2021
- 资助金额:
$ 0.65万 - 项目类别:
Emory Initiative to Maximize Student Development
埃默里大学最大化学生发展计划
- 批准号:
10417181 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
Insight into the RNA processing and decay pathways critical for proper neuronal development and function through focus on mutations that cause Pontocerebellar Hypoplasia
通过关注导致脑桥小脑发育不全的突变,深入了解对神经元正常发育和功能至关重要的 RNA 加工和衰变途径
- 批准号:
10198947 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
Insight into the RNA processing and decay pathways critical for proper neuronal development and function through focus on mutations that cause Pontocerebellar Hypoplasia
通过关注导致脑桥小脑发育不全的突变,深入了解对神经元正常发育和功能至关重要的 RNA 加工和衰变途径
- 批准号:
10414387 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
Insight Into The RNA Processing And Decay Pathways Critical For Proper Neuronal Development And Function Through Focus On Mutations That Cause Pontocerebellar Hypoplasia
通过关注导致脑桥小脑发育不全的突变,深入了解对神经元正常发育和功能至关重要的 RNA 加工和衰变途径
- 批准号:
10268003 - 财政年份:2018
- 资助金额:
$ 0.65万 - 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Opioid-Sparing Non-Surgical, Bioresorbable Nerve Stimulator for Pain Relief
节省阿片类药物的非手术生物可吸收神经刺激器,用于缓解疼痛
- 批准号:
10759642 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
5T-IV: photoacoustic needle with beacon pulse for ultrasound guided vascular access with Tool-Tip Tracking and Tissue Typing
5T-IV:带有信标脉冲的光声针,用于通过工具提示跟踪和组织分型进行超声引导血管通路
- 批准号:
10677283 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Development of a rapid screening test for the detection of dihydroanatoxin-a
开发检测二氢虾毒素-a 的快速筛选试验
- 批准号:
10545266 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Emergent behavioral and transcriptional properties of pair bonds
配对键的新兴行为和转录特性
- 批准号:
10750878 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别:
Smoking-related Differences in Baroreflex Sensitivity and Fear Inhibition in Adults Who Do and Do Not Smoke Cigarettes
吸烟和不吸烟的成年人压力感受反射敏感性和恐惧抑制的与吸烟相关的差异
- 批准号:
10607239 - 财政年份:2023
- 资助金额:
$ 0.65万 - 项目类别: